Back
Penumbra Vs. ResMed Industry Stock Comparison
Buy
74
PEN
Penumbra
Last Price:
$242.15
Seasonality Move:
11.69%
Sell
42
RMD
ResMed
Last Price:
$237.62
Seasonality Move:
4.35%
Sell
42
ResMed (RMD)
is a Sell
Is ResMed a Buy, Sell or Hold?
-
RMD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PEN Stock Price Chart
PEN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.31 | Buy |
Relative Strength Index (14 RSI): | 52.04 | Buy |
Chaikin Money Flow: | -379749 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (239.51 - 248.11) | Sell |
Bollinger Bands (100): | (186.65 - 235.65) | Buy |
RMD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.01 | Sell |
Relative Strength Index (14 RSI): | 45.38 | Sell |
Chaikin Money Flow: | 1840254 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (237.09 - 247.47) | Sell |
Bollinger Bands (100): | (228.48 - 248.96) | Sell |
PEN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 246.4 | Sell |
20-day SMA: | 245.01 | Sell |
50-day SMA: | 231.1 | Buy |
200-day SMA: | 206.5 | Buy |
8-day EMA: | 244.2 | Sell |
20-day EMA: | 242.83 | Sell |
50-day EMA: | 232.14 | Buy |
200-day EMA: | 217.16 | Buy |
RMD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 238.69 | Sell |
20-day SMA: | 242.98 | Sell |
50-day SMA: | 242.52 | Sell |
200-day SMA: | 219.74 | Buy |
8-day EMA: | 237.82 | Sell |
20-day EMA: | 240.69 | Sell |
50-day EMA: | 240.94 | Sell |
200-day EMA: | 222.98 | Buy |
Penumbra Earnings Growth & PEN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.76 per share, and an increase next year of $1.02 per share.
ResMed Earnings Growth & RMD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.18 per share, and an increase next year of $1.66 per share.
Penumbra Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ResMed Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |